In fact, the WHO classification of tumors will be updated soon, in 2021, and include the need of analysis for chromosome 7 and loss of whole chromosome 10, and TERT promoter mutation and EGFR amplification for the diagnosis of glioblastoma even though the tumor has histologically low grade glioma features. This evidence concerns the gene EGFR and neoplasm.